跳至主要内容
临床试验/JPRN-UMIN000017148
JPRN-UMIN000017148已完成2 期

An open randomized controlled study of topical B blocker gel for the treatment of infantile hemangioma: Comparison of safety and efficacy among topical 0%, 1% 5% B blocker gel. - A controlled study of B blocker gel for the treatment of infantile hemangioma

Chiba University0 个研究点目标入组 19 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
19

研究概览

简要总结

In the PPS, the main endpoint, the rate of change in the average number of brightness in the area where the tumor exists after 6 months, three groups are same, ie, 0.9. There was no difference. A difference in the average number of brightness in the area where the tumor exists after 6 months was examined. A tendency was observed that the number of brightness decreased.

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 15years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have asthma, cardiovascular malformation, diabetes, medication (including adrenaline, beta-blocker, calcium antagonist agent, digitalis product, CYP2D6 inhibitor), other skin disease, many infant hemangioma, congenital hemangioma. Patients who are ruled unfit to this study.

研究者

相似试验